Legal & General Group PLC Aligos Therapeutics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.04 - $2.14 $8,134 - $16,739	-7,822 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.57 - $17.72 $75,399 - $91,701	5,175 Added 195.5%	7,822 $121,000
Q2 2021 Aug 12, 2021	BUY	$20.3 - $33.6 $32,520 - $53,827	1,602 Added 153.3%	2,647 $53,000
Q4 2020 Feb 12, 2021	BUY	$13.2 - $32.74 $13,794 - $34,213	1,045 New	1,045 $29,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.